ECV (TPEx:6689) announced its revenue for February 2023.
4.6 (415) · € 36.50 · En Stock
ECV (TPEx:6689) announced its revenue for February 2023.
China's Nov NEV wholesale sales hit record 940,000 units, CPCA estimates show - CnEVPost
CPCA expects China Sept NEV retail sales to be record 750,000 units - CnEVPost
November 2023 FOMC Preview: Long Yields Encourage Restraint
2023 nine-month revenue: €98.8 million, up +3% - FY 2023 guidance adjusted
EDGAR Filing Documents for 0000950170-22-008970
ESMO 2023: LITESPARK-005 Belzutifan Versus Everolimus in Participants with Previously Treated Advanced Clear Cell Renal Cell Carcinoma: Randomized Open-Label Phase 3
Document
ECV (TPEx:6689) announced its revenue for September 2023.
EDGAR Filing Documents for 0001104659-23-060152
